-
Oct. 2018
Rentschler Biopharma and LEUKOCARE to announce findings of recent international Drug Product Formulation Survey at BIO-Europe® 2018
-
Sep. 2018
LEUKOCARE presenting at 12th Vaccine Congress in Budapest, Hungary
-
Sep. 2018
LEUKOCARE and Xellia Pharmaceuticals partner to discover innovative formulations for the development of value-added anti-infective therapies
-
Jun. 2018
LEUKOCARE grants a license on its SPS® formulation technology platform to Laboratorios Liomont for development and commercialization of a biosimilar
-
Apr. 2018
LEUKOCARE and Boehringer Ingelheim enter into a long-term agreement in the field of animal health
-
Mar. 2018
Rentschler Biopharma and Leukocare demonstrate success of strategic alliance for biopharmaceutical development and formulation
-
Sep. 2017
LEUKOCARE continues to expand and invests in research and development
-
Feb. 2017
Rentschler and Leukocare announce strategic alliance and equity investment
-
Sep. 2016
LEUKOCARE grants license to US vaccine company PaxVax
-
Jul. 2016
Dr. Andreas Rummelt, pharma industry expert and former CEO of Sandoz, was elected as new supervisory board member at LEUKOCARE’s annual shareholder meeting on July 12th.